ArticleAdvances in therapy2020

PF-06881894, a Proposed Biosimilar to Pegfilgrastim, Versus US-Licensed and EU-Approved Pegfilgrastim Reference Products (Neulasta

Shahrzad Moosavi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.